News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,309 Results
Type
Article (17721)
Company Profile (130)
Press Release (385458)
Multimedia
Podcasts (55)
Webinars (11)
Section
Business (132041)
Career Advice (992)
Deals (23559)
Drug Delivery (81)
Drug Development (41105)
Employer Resources (67)
FDA (8786)
Job Trends (9975)
News (212197)
Policy (20484)
Tag
Academia (1142)
Accelerated approval (3)
Adcomms (10)
Allergies (48)
Alliances (35641)
ALS (39)
Alzheimer's disease (565)
Antibody-drug conjugate (ADC) (50)
Approvals (8818)
Artificial intelligence (169)
Autoimmune disease (9)
Automation (7)
Bankruptcy (212)
Best Places to Work (7697)
BIOSECURE Act (14)
Biosimilars (67)
Biotechnology (55)
Bladder cancer (32)
Brain cancer (17)
Breast cancer (127)
Cancer (980)
Cardiovascular disease (100)
Career advice (845)
Career pathing (15)
CAR-T (34)
Cell therapy (156)
Cervical cancer (11)
Clinical research (34360)
Collaboration (514)
Compensation (340)
Complete response letters (18)
COVID-19 (1213)
CRISPR (27)
C-suite (156)
Cystic fibrosis (47)
Data (951)
Decentralized trials (1)
Denatured (17)
Depression (15)
Diabetes (106)
Diagnostics (3799)
Digital health (11)
Diversity (4)
Diversity, equity & inclusion (17)
Drug discovery (78)
Drug pricing (93)
Drug shortages (14)
Duchenne muscular dystrophy (41)
Earnings (48124)
Editorial (22)
Employer branding (5)
Employer resources (57)
Events (54802)
Executive appointments (532)
FDA (9465)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (345)
Gene editing (51)
Generative AI (12)
Gene therapy (139)
GLP-1 (418)
Government (2914)
Grass and pollen (5)
Guidances (38)
Healthcare (10606)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (43)
Indications (18)
Infectious disease (1287)
Inflammatory bowel disease (70)
Inflation Reduction Act (8)
Influenza (29)
Intellectual property (59)
Interviews (151)
IPO (9594)
IRA (43)
Job creations (2557)
Job search strategy (735)
Kidney cancer (6)
Labor market (20)
Layoffs (240)
Leadership (7)
Legal (4736)
Liver cancer (25)
Lung cancer (136)
Lymphoma (76)
Machine learning (2)
Management (22)
Manufacturing (225)
MASH (36)
Medical device (5755)
Medtech (5758)
Mergers & acquisitions (14329)
Metabolic disorders (324)
Multiple sclerosis (29)
NASH (14)
Neurodegenerative disease (31)
Neuropsychiatric disorders (10)
Neuroscience (800)
NextGen: Class of 2025 (4130)
Non-profit (2661)
Now hiring (10)
Obesity (180)
Opinion (141)
Ovarian cancer (29)
Pain (60)
Pancreatic cancer (25)
Parkinson's disease (57)
Partnered (14)
Patents (142)
Patient recruitment (39)
Peanut (18)
People (41006)
Pharmaceutical (67)
Pharmacy benefit managers (12)
Phase I (9127)
Phase II (14709)
Phase III (12765)
Pipeline (699)
Policy (126)
Postmarket research (1531)
Preclinical (3691)
Press Release (70)
Prostate cancer (63)
Psychedelics (16)
Radiopharmaceuticals (156)
Rare diseases (206)
Real estate (4454)
Recruiting (24)
Regulatory (14086)
Reports (18)
Research institute (1090)
Resumes & cover letters (144)
Rett syndrome (1)
RNA editing (2)
RSV (13)
Schizophrenia (45)
Series A (48)
Series B (23)
Service/supplier (15)
Sickle cell disease (39)
Special edition (10)
Spinal muscular atrophy (85)
Sponsored (17)
Startups (2137)
State (2)
Stomach cancer (3)
Supply chain (51)
Tariffs (37)
The Weekly (36)
Vaccines (245)
Venture capitalists (16)
Weight loss (120)
Women's health (16)
Worklife (7)
Date
Today (85)
Last 7 days (383)
Last 30 days (1305)
Last 365 days (17517)
2025 (5683)
2024 (18824)
2023 (21642)
2022 (30000)
2021 (32056)
2020 (32664)
2019 (29691)
2018 (22698)
2017 (19837)
2016 (19103)
2015 (22066)
2014 (17252)
2013 (14640)
2012 (15867)
2011 (16684)
2010 (15013)
Location
Africa (456)
Alabama (23)
Alaska (5)
Arizona (107)
Arkansas (8)
Asia (25561)
Australia (3401)
California (2712)
Canada (1437)
China (298)
Colorado (148)
Connecticut (133)
Delaware (84)
Europe (53888)
Florida (480)
Georgia (81)
Hawaii (1)
Idaho (25)
Illinois (374)
India (19)
Indiana (199)
Iowa (3)
Japan (113)
Kansas (75)
Kentucky (21)
Louisiana (6)
Maine (27)
Maryland (538)
Massachusetts (2096)
Michigan (106)
Minnesota (161)
Mississippi (2)
Missouri (46)
Montana (16)
Nebraska (15)
Nevada (29)
New Hampshire (26)
New Jersey (1055)
New Mexico (18)
New York (767)
North Carolina (638)
North Dakota (5)
Northern California (1113)
Ohio (131)
Oklahoma (10)
Oregon (19)
Pennsylvania (757)
Puerto Rico (8)
Rhode Island (21)
South America (711)
South Carolina (5)
Southern California (1092)
Tennessee (67)
Texas (445)
United States (11594)
Utah (63)
Virginia (104)
Washington D.C. (48)
Washington State (202)
West Virginia (3)
Wisconsin (36)
403,309 Results for "camargo pharmaceutical services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Premier Research Acquires Camargo Pharmaceutical Services
Premier Research announced that it has acquired Camargo Pharmaceutical Services based in Cincinnati.
May 18, 2021
·
3 min read
Deals
Camargo Pharmaceutical Services Acquires Paidion Research
Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) based in Durham, N.C.
March 2, 2021
·
2 min read
Press Releases
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
January 22, 2025
·
2 min read
Press Releases
Biotechnology and Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report by 2034
January 21, 2025
·
1 min read
Business
Reeves McGee Appointed Chief Commercial Officer at Camargo Pharmaceutical Services, LLC
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Reeves McGee as Chief Commercial Officer. In this senior leadership role, McGee will oversee the development and implementation of Camargo’s commercial strategies, its commercial organic growth initiatives and the
October 13, 2020
·
2 min read
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.
Aurigene Pharmaceutical Services Ltd. (Aurigene), a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche small-molecule drug discovery service provider specialized in DEL technologies, entered into a strategic partnership.
April 19, 2024
·
3 min read
Business
Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application
February 8, 2021
·
4 min read
Business
Jennie Orr Appointed Chief Strategy and Business Officer at Camargo Pharmaceutical Services, LLC
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced the appointment of Jennie Orr as Chief Strategy and Business Officer.
October 13, 2020
·
2 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
February 6, 2025
·
13 min read
1 of 40,331
Next
